Learn More
Medchemexpress LLC Furazolidone | 67-45-8 | MFCD00010550 | 1 ML

Supplier: Medchemexpress LLC HYB133610MM/1ML
Furazolidone is a monoamine oxidase (MAO) inhibitor that possesses antiproliferative, apoptosis-inducing, and differentiation-promoting characteristics. It has the potential to inhibit leukemia fusion protein-mediated bone marrow transformation by increasing the stability of the tumor suppressor protein p53. Furthermore, Furazolidone demonstrates anti-leukemic activity in acute myeloid leukemia (AML) cell lines and is suitable for anti-AML research.
- Monoamine oxidase (MAO) inhibitor.
- Exhibits antiproliferative activity.
- Induces apoptosis.
- Promotes differentiation.
- May inhibit leukemia fusion protein-mediated bone marrow transformation.
- Upregulates the stability of tumor suppressor protein p53.
- Shows anti-leukemic activity in acute myeloid leukemia (AML) cell lines.
- Can be used for anti-AML research.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.